UPDATE: Pacira Pharma (PCRX) Tops Q3 EPS by 23c, Revenues Beat; Boosts FY18 Revenue Outlook

Go back to UPDATE: Pacira Pharma (PCRX) Tops Q3 EPS by 23c, Revenues Beat; Boosts FY18 Revenue Outlook
PACIRA (NASDAQ: PCRX) Delayed: 23.05 +0.34 (1.50%)
Previous Close $22.71    52 Week High $80.25 
Open $22.90    52 Week Low $30.25 
Day High $23.21    P/E N/A 
Day Low $22.81    EPS $-2.08 
Volume 67,308